Filing Details

Accession Number:
0000899243-23-006582
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-01 16:15:19
Reporting Period:
2023-02-27
Accepted Time:
2023-03-01 16:15:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590560 Uniqure N.v. QURE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711885 Christian Klemt C/O Uniqure N.v.
Paasheuvelweg 25A
Amsterdam P7 11058BP
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-02-27 9,824 $20.10 136,796 No 4 S Direct
Ordinary Shares Disposition 2023-02-28 1,369 $20.90 135,427 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.85 to $20.43. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. 1,363 of the shares were sold at $20.90 and 6 of the shares were sold at $21.35.